Many studies have shown that KRAS mutation in pancreatic cancer is significantly correlated with shorter overall survival, whereas only a few studies have shown an absence of a correlation [30,31,32,33,34,35,36,37]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.